A mutation, car, determining resistance to several macrolide antibiotics, including carbomycin, has been identified in the alga Chlamydomonas as cytoplasmic, and mapped in the known cytoplasmic linkage group close to genes determining resistance to other antibiotics, including streptomycin, erythromycin, and spectinomycin. The A serious gap in our understanding of cellular organization concerns the precise functional role of cytoplasmic genes (1). All cytoplasmic genes so far examined in the alga Chlamydomonas reinhardi show the same pattern of maternal inheritance and map within the same linkage group, long postulated to be located in chloroplast DNA and to code for numerous chloroplast proteins (1-4). Gillham et al. (5) have reported that chloroplast ribosomes from some cytoplasmic mutants of Chlamydomonas were 66 S rather than 70 S, and Mets and Bogorad (6) found that chloroplast ribosomes from a cytoplasmic erythromycin-resistant mutant were impaired in their erythromycin-binding ability. This paper reports the correlation between a mutation to resistance to the macrolide antibiotic carbomycin, that maps in the cytoplasmic linkage group and an alteration in chloroplast ribosome function, attributed to a change in a ribosomal protein.
spectinomycin. The A serious gap in our understanding of cellular organization concerns the precise functional role of cytoplasmic genes (1) . All cytoplasmic genes so far examined in the alga Chlamydomonas reinhardi show the same pattern of maternal inheritance and map within the same linkage group, long postulated to be located in chloroplast DNA and to code for numerous chloroplast proteins (1) (2) (3) (4) . Gillham et al. (5) have reported that chloroplast ribosomes from some cytoplasmic mutants of Chlamydomonas were 66 S rather than 70 S, and Mets and Bogorad (6) found that chloroplast ribosomes from a cytoplasmic erythromycin-resistant mutant were impaired in their erythromycin-binding ability. This paper reports the correlation between a mutation to resistance to the macrolide antibiotic carbomycin, that maps in the cytoplasmic linkage group and an alteration in chloroplast ribosome function, attributed to a change in a ribosomal protein.
We compare the effects of antibiotics on the proteinsynthesizing activity of 70S chloroplast ribosomes from wildtype and antibiotic-resistant mutant strains. For this purpose it was necessary to develop an in vitro protein-synthesizing system that used chloroplast ribosomes. This paper reports the first demonstration of in vitro incorporating activity of chloroplast ribosomes from Chlamydomonas. We show that high concentrations of Mg++ and spermidine activate 70S chloroplast ribosomes, and low concentrations activate 80S cytoplasmic ribosomes. Both in S-30 extracts and in fractionated systems, the 70S ribosomes of the resistant mutant were resistant to carbomycin, whereas the ribosomes from the wildtype strain were sensitive. (3-4 min) . The S-30 fraction was prepared as described (8) by centrifugation at 10,000 X g for 10 min; the supernatant (S-10) was centrifuged at 30,000 X g for 30 min. For preparation of the S-122 fraction, S-30 was centrifuged at 122,000 X g for 4 chloroacetic acid were added to each tube before heating. In the ribosome-S-122 system, the reaction mixtures were incubated at 350 for 60 min, chilled, and 200 ,ug of bovineserum albumin plus 1 ml of 10% trichloroacetic acid were added before heating.
Materials. Carbomycin was the generous gift of Chas. Pfizer & Co.; phosphoenol pyruvate, pyruvate kinase, and cycloheximide ("Actidione") were purchased from Calbiochem; Omnifluor and ['4C]phenylalanine from New England Nuclear; puromycin dihydrochloride, bovine-serum albumin, and spermidine trihydrochloride, from Sigma Chem. Co.; chloramphenicol, E. coli B tRNA, and sucrose (special density gradient grade) from Schwarz/Mann; ATP and GTP from P-L Biochemicals; and poly(U) from Miles Laboratories.
Carbomycin solutions were freshly prepared for each experiment.
RESULTS
Genetic characterization of the car mutation A car mutation was recovered after streptomycin mutagenesis (9) . Wild-type cells of plus mating type (mt+) were incubated 6 days on agar medium containing 20 ,ug/ml of streptomycin, washed off, and replated on agar medium containing 50 Ag/ml of carbomycin. One of the mutant colonies growing on carbomycin-agar, called car-1 and chosen for further study, was subcultured in the absence of the drug and tested at each subculture for maintenance of resistance. Cells remained uniformly resistant to 150 ug/ml of carbomycin after many doublings in the absence of the drug, and the mutant was therefore considered genetically resistant (car-r).
The mutant strain (mt+ car-r) was crossed with a tester stock carrying three nuclear and three cytoplasmic markers (2) , and one of the resulting F1 progeny (mt-) was backcrossed to an mt+ tester, with the same sets of nuclear and cytoplasmic marker genes. In both crosses, the car gene showed typical maternal inheritance: transmission to all progeny of the allele from the mt+ parent, except for rare instances of spontaneous biparental transmission. In the F1 backcross (mt+ car-s x mt-car-r) all progeny (scored as zygote colonies) were sensitive to carbomycin except for a r r~~~C residual 0.6%, which grew on carbomycin-agar and represented examples of spontaneous biparental transmission.
Further evidence of the maternal inheritance pattern of the car gene is based on the results of UV-irradiation of the mt+ parent just before mating, a procedure that increases the frequency of biparental transmission of cytoplasmic genes (10) . When the mt+ parent in the F] backcross (mt+ car-s) was irradiated, the frequency of zygote colonies growing on carbomycin agar increased from 0.6 to 80% of the total zygote colonies growing in the absence of the drug. Thus, the car mutation was shown to be cytoplasmic both by its pattern of maternal transmission in unirradiated controls and by its biparental transmission pattern after UV irradiation of the mt+ parent.
Genetic linkage of the car gene was determined in crosses involving the linked cytoplasmic genes ery (erythromycin resistance), spc (spectinomycin resistance), and sm2 (streptomycin resistance), by methods developed in this laboratory (1, 2, 10 ). The car gene was found to lie between spc and sm2 and to be tightly linked to ery (1). In separate crosses, the genes spi and ole, conferring resistance to the related macrolide antibiotics spiramycin and oleandomycin, were also found to be tightly linked to ery (1) . The four genes, ery, car, spi, and ole, may actually represent different mutations of the same gene (Sager & Ramanis, unpublished) . Many macrolide antibiotics inhibit protein synthesis in bacterial ribosomes (11) and bind to the 50S ribosomal subunit (12) .
Protein synthesis on cytoplasmic and chloroplast ribosomes of wild-type Chlamydomonas An in vitro system was developed to examine the effect of carbomycin on Chlamydomonas protein synthesis. Two classes of ribosomes have been identified in extracts of Chlamydomonas: cytoplasmic ribosomes sedimenting at 80 S and chloroplast ribosomes sedimenting at 70 S (13, 14) .
Incorporation activity of an S-30 extract stimulated by poly(U) has been described (8) . Chloroplast ribosomes are inactive in this system. Fig. 1 shows that when an S-30 extract was incubated (8) and then centrifuged through a 10-30% sucrose gradient two absorbance peaks were seen, correspond- ing to the two ribosome classes (see ref. 14) , but amino-acidincorporating activity was associated only with the 80S peak.
[The absence of counts at the top of the gradient indicated that, as in other systems (15) , peptide chains were not released from the active ribosome complex when poly(U) was used as messenger. 1 Table 1 shows the results of incubation of an S-30 extract under the same conditions as in Fig. 1 , in the presence of cycloheximide, chloramphenicol, or carbomycin. Cycloheximide inhibited protein synthesis 85%, whereas chloramphenicol and carbomycin had little or no effect. These findings are in accord with the sensitivity of cytoplasmic ribosomes from other eukaryotes to cycloheximide and not to chloramphenicol (see ref. 14) .
In contrast, incorporation on chloroplast ribosomes was obtained when the S-30 system was incubated at 25 mM Mg++ and 3.3 mM spermidine ( Fig. 2A) . Essentially no activity was associated with the 80S ribosomal peak. In contrast with cytoplasmic ribosomes, the activity associated with the 70S peak was resistant to cycloheximide (Fig. 2B ) and sensitive to chloramphenicol (Fig. 2C) . In an experiment without gradients, chloroplast ribosomes from the wild-type strain were sensitive to carbomycin (8 ,M gave 70% inhibition). Activity on chloroplast ribosomes was obtained in a range of Mg++ concentrations from 25-50 mM in the absence of added spermidine. However, a combination of 3.3 mM spermidine with 25 mM Mg++ gave twice the activity seen with Mgg++ alone, and was used in all subsequent experiments.
Thus, wild-type cytoplasmic ribosomes were active in an S-30 system containing 10 mM Mg++ but inactive in 25 mM Mg++ plus 3.3 mM spermidine, sensitive to cycloheximide, and resistant to chloramphenicol and carbomycin. On the other hand, wild-type chloroplast ribosomes were inactive at 10 mM Mg++ but functional at the higher magnesium and spermidine concentrations, resistant to cyclohexinide, and sensitive to chloramphenicol and carbomycin. Fig. 3 . Carbomycin had no effect on incorporation with the mutant S-30 preparation but decreased both the rate and extent of phenylalanine incorporation with the wild-type extract.
A further comparison is given in Chloroplast ribosomes were prepared by pooling the 70S peak fractions from S-30 extracts centrifuged through sucrose gradients. In the purified recombined system, activities were 10-times higher than those usually found with S-30 extracts incubated under the same conditions (25 mM Mg++ and 3.3 mM spermidine). Perhaps an inhibitor was removed from the ribosomes in the gradient. As shown in Table 3 , the homologous system from the wild-type components incorporated 1292 pmol of phenylalanine per mg ribosomes, and the homologous car system incorporated 1725 pmol.
With the heterologous systems, carbomycin inhibited incorporation with wild-type ribosomes, but not with ribosomes from the car mutant. Thus, the chloroplast ribosome itself (or some tightly bound component) was altered by the cytoplasmic mutation to carbomycin resistance.
DISCUSSION
This report has described a cytoplasmic mutation, car, to carbomycin resistance, located in the previously described (1-3) cytoplasmic linkage group of Chlamydomonas, and has shown that this mutation alters chloroplast ribosome function. An in vitro system incorporating amino acids was developed to examine the effect of the car mutation on chloro- The development of a highly active in vitro system that incorporates amino acids using chloroplast ribosomes, after numerous failures (Sager, unpublished) , resulted from the use of high concentrations of Mg++ and spermidine. Although added spermidine is not essential, it appears to act as in other systems (16) to enhance activity. In Chlamydomonas, 70S chloroplast ribosomes have a much higher Mg++ requirement for structural integrity (13, 14) than do 80S ribosomes, and a higher Mg++ optimum for activity. At 25 mM Mg++ spermidine doubles the activity of the chloroplast ribosomes and inactivates the 80S cytoplasmic ribosomes, providing conditions for examining 70S ribosome activity in S-30 extracts without fractionation.
The higher Mg++ optimum for chloroplast than for 80S ribosomes observed in Chlamydomonas parallels the higher Mg++ requirements generally observed for amino-acid incorporation and monomer stability of 70S bacterial ribosomes than of 80S eukaryotic ribosomes. In addition, the Mg++ optimum for incorporation on ribosomes isolated from yeast mitochondria (21) or from tobacco leaf chloroplasts (22) was higher than that of their cytoplasmic ribosomes.
The activities observed (1292 and 1725 pmol of phenylalanine per mg ribosomes) with the chloroplast ribosome-S-122 system from Chlamydomonas approach those found with E. coli. Other preparations with ribosomes derived from organelles require addition of E. coli supernatant factors for comparable high amounts of incorporation (23, 24) .
Numerous similarities between bacterial and chloroplast protein-synthesizing systems have been described (1) . In particular, bacteria and chloroplasts are sensitive to certain classes of antibiotics, including the macrolides, aminoglycosides, spectinomycin, and chloramphenicol, all known to inhibit protein synthesis (12) . As in bacteria, mutations have been recovered in Chlamydomonas conferring resistance to many of these antibiotics (1) . Some of the mutations are nuclear, and their effects at the molecular level are largely unknown. The cytoplasmic mutations, presumably located in chloroplast DNA, have been examined with the view that they may resemble the bacterial ones that alter ribosomal proteins.
Our findings support this hypothesis. The car mutant cells are resistant to carbomycin and also to the related macrolides, spiramycin and oleandomycin; and their chloroplast ribosomes show parallel resistance to carbomycin and spiramycin in protein synthesis in vitro.
A further similarity between bacterial and chloroplast systems lies in the linkage relations of genes conferring resistance to antibiotics and presumably (in some instances, known to be) coding for ribosomal proteins. The gene order str-nea-kan-ery-spc reported in Bacillus subtilis (17) closely resembles the gene order sm2-nea-(ery,car,spiole)-spc that we have found in Chlamydomonas (1) .
Although the existence of chloroplast DNA has been known since 1963 (18, 19) and cytoplasmic genes affecting chloroplast development were first described in 1909 (1), as yet not a single protein has been definitely identified as a chloroplast gene protein. The evidence that erythromycin-resistant strains of E. coli have an altered protein, 50-8, of the 50S ribosomal subunit (20) , increases the likelihood that the car gene product is a protein of the chloroplast 50S ribosomal subunit.
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